Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery
Illumina introduced three early-access capabilities on its BioInsight Platform: Workflow Orchestrator, DRAGEN Ultra, and Learning Cohorts, aimed at automating end-to-end genomic informatics at scale. DRAGEN Ultra extends analysis beyond variant calling using AI models; its new dnaAI variant-prioritization model produced an 8% increase in disease associations across unsolved cases and ranked known disease-associated variants in the top four candidates in 99.4% of genomes analyzed.
Key figures
- Dna AI top4 rank rate
- 99.4%
- Dna AI disease association lift
- 8% increase in disease associations across unsolved cases
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.